How many times a day should you take Axitinib (Inlida) and how to maintain regular medication
Axitinib is an oral small molecule tyrosine kinase inhibitor mainly used for the treatment of advanced renal cell carcinoma. It blocks tumor angiogenesis by selectively inhibiting vascular endothelial growth factor receptors (VEGFR) 1, 2, 3, thereby inhibiting tumor growth and metastasis. Due to the absorption and metabolism characteristics of drugs in the body, regular medication is essential to maintain stable blood drug concentrations and ensure efficacy.
Usually, it is recommended to take axitinib orally twice a day, with an interval of about 12 hours between each time, to keep the blood concentration relatively stable and avoid excessive peak and trough fluctuations. Patients can adjust the dosage according to the guidance of their doctor, but are not allowed to increase or decrease it at will. Fixed doses and medication intervals help improve drug efficacy while reducing the risk of side effects such as high blood pressure, fatigue, and diarrhea.

In order to maintain regular medication use, patients should choose a fixed medication time, such as taking medication at the same time every morning and evening, and combine it with their daily habits. Alarm clocks, pill boxes or cell phone reminders can be used to help remember and avoid missing or repeated doses. If you miss a dose, you should take it as soon as you realize it. However, if it is close to the time of the next dose, skip the missed dose and continue as originally planned.
In addition, patients should pay attention to diet and life management while taking the medicine. Axitinib can be taken with food or on an empty stomach, but you should avoid taking high-fat or calcium- and magnesium-containing antacids at the same time to avoid affecting absorption. Maintaining sufficient fluids, regularly monitoring blood pressure and blood routine, and conducting regular follow-up visits as directed by the doctor can help doctors evaluate efficacy and tolerance and achieve safe, stable and scientific individualized medication management.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)